Stryker Stock News

Market Snapshot A recently published report by QY Research, titled Global Operating Room (OR) Integration System Market Size, Status and Forecast 2022 gives an overview of the overall Operating Room (OR) Integration System market. This section sheds light on key

DBMR has added a new report titled Medical Robots Transforming Healthcare Market with data Tables for historical and forecast years represented with Chats & Graphs spread through Pages with easy to understand detailed analysis. It is a completely informative and

DBMR has added another report named Medical Robots Market with information Tables for recorded and figure years addressed with Chats and Graphs spread through Pages with straightforward definite examination. The a-list report concentrates on broad assessment of the market development

Market Players for Global Laparoscopy Devices Market Stryker Corporation, Karl Storz GmbH & Co KG, Boston Scientific Corporation, Medtronic PLC, Intuitive Surgical, (Japan), Karl Storz GmbH, Olympus Corporation, Microline Surgical, Medtronic PLC. Johnson & Johnson, Olympus Corporation, Conmed Corporation Market Players for Global Laparoscopy Devices Market Stryker Corporation, Karl Storz GmbH & Co KG, Boston Scientific Corporation, Medtronic PLC, Intuitive Surgical, (Japan), Karl Storz GmbH, Olympus Corporation, Microline Surgical, Medtronic PLC. Johnson & Johnson, Olympus Corporation, Conmed Corporation

SF: The United States Army is about to upgrade its Stryker Infantry Carrier Vehicle (ICV) with a better mobile Short Range Air Defense (SHORAD) capability. The manufacturer, General Dynamics Land Systems teamed up with counter-drone startup Epirus Inc. to deliver counter unmanned aerial systems technology. The partnership will initially integrate Epiruss Leonidas directed energy system [] The post US Army Stryker Vehicle Receives Drone Swarm Protection first appeared on Veterans Today | Military Foreign Affairs Policy Journal for Clandestine Services .

Hall Laurie J Trustee decreased its position in Stryker Co. (NYSE:SYK) by 4.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 33,792 shares of the medical technology companys stock after selling 1,433 shares during the quarter. Stryker accounts for about []

Stryker: A Q3 Earnings Hiccup In A Broader Bullish Trend

Despite pandemic-led disruptions, Stryker's (SYK) third-quarter earnings reflect strong performance across Orthopaedics, MedSurg and Neurotechnology and Spine segments.

Stryker Corporation (SYK) CEO Kevin Lobo on Q3 2021 Results - Earnings Call Transcript

Stryker (SYK) delivered earnings and revenue surprises of -3.51% and -1.91%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Stryker's (SYK) third-quarter results are likely to reflect strong segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine.

Why Stryker Is A Gift For Growth Investors

These two blue-chip healthcare stocks can help long-term investors sleep well at night.

Kalamazoo, Michigan, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host an Analyst Meeting on Thursday, November 18, 2021, at 2:30 p.m. Eastern Time, in Mahwah, New Jerse

We think that Stryker stock (NYSE: SYK) currently is a better pick compared to Boston Scientific stock, despite Stryker being slightly more expensive of the two. Stryker trades at about 6.4x trailing